A historic shift in our drug policy has taken place, as the authorities announce the availability of psilocybin mushrooms for therapeutic purposes. Until now, these substances were strictly restricted, but a growing body of research suggests they potentially offer aid for psychological illnesses like PTSD. This development represents a key step tow